Product image of Ondansetron Kalceks (Ondansetron) supplied by GNH India

Ondansetron Kalceks

Active Ingredient:
Ondansetron
Origin:
EU

Ondansetron Kalceks (Ondansetron)

Ondansetron, the active ingredient in Ondansetron Kalceks, is a 5‑HT3 receptor antagonist presented as a tablet for oral use. It is employed to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery, and is authorized for distribution within the European Union market.

GNH India supplies Ondansetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron is a selective 5‑HT3 receptor antagonist used to manage nausea and vomiting across several clinical pathways.

  • Chemotherapy‑induced nausea and vomiting: reduces incidence and severity of nausea and vomiting in cancer patients receiving cytotoxic therapy.
  • Radiation‑induced nausea and vomiting: helps control nausea associated with abdominal or pelvic radiation.
  • Postoperative nausea and vomiting: prevents nausea and vomiting after surgical procedures.

How It Works

  • Ondansetron blocks serotonin (5‑HT3) receptors located centrally in the chemoreceptor trigger zone and peripherally on vagal nerve terminals. By inhibiting these receptors, it prevents the initiation of the vomiting reflex triggered by chemotherapeutic agents, radiation, or surgical stimuli, thereby reducing nausea and emesis.

Side Effects

Common Side Effects

  • Headache: mild to moderate pain often reported.
  • Constipation: reduced bowel movements.
  • Dizziness: sensation of light‑headedness.
  • Fatigue: feeling of tiredness.
  • Diarrhoea: loose stools.
  • Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects

  • QT prolongation: potential cardiac rhythm disturbance.
  • Severe allergic reaction (anaphylaxis): swelling, rash, breathing difficulty.
  • Serotonin syndrome: agitation, hyperthermia, muscle rigidity.
  • Severe hypotension: marked drop in blood pressure.
  • Cardiac arrhythmia: irregular heartbeats.
  • Hepatic dysfunction: abnormal liver enzyme elevations.

Precautions & Warnings

Before initiating therapy, consider the following precautions:

  • Cardiac assessment: evaluate risk of QT interval prolongation.
  • Electrolyte balance: correct hypokalemia or hypomagnesemia.
  • Concomitant QT‑prolonging drugs: avoid combined use when possible.
  • Hepatic impairment: dose adjustment may be required.
  • Pregnancy considerations: discuss risk‑benefit with prescriber.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Ondansetron may interact with several drug classes; monitoring is essential.

Major Interactions (Avoid)

  • Other QT‑prolonging agents: increased risk of cardiac arrhythmia.
  • Apomorphine: can cause severe hypotension and loss of consciousness.
  • Serotonergic drugs (e.g., SSRIs, MAO inhibitors): heightened risk of serotonin syndrome.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may raise ondansetron plasma concentrations.
  • CYP3A4 inducers (e.g., rifampin): may lower ondansetron plasma concentrations.
  • Anticholinergic agents: may diminish antiemetic efficacy.

Frequently Asked Questions

Ondansetron Kalceks contains the antiemetic agent ondansetron and is used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, and postoperative recovery in adult and pediatric patients, as directed by a healthcare professional.

Ondansetron works by selectively blocking serotonin type 3 (5‑HT3) receptors in the central chemoreceptor trigger zone and on peripheral vagal nerve endings, interrupting the signaling pathway that initiates the vomiting reflex.

The appropriate dose of Ondansetron Kalceks is determined by the prescribing clinician based on the indication, patient age, weight, renal and hepatic function, and other individual factors. No fixed regimen is provided here.

Safety in pregnancy and lactation has not been fully established. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the prescribing physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ondansetron belongs to the 5‑HT3 receptor antagonist class, offering a rapid onset and specific action against serotonin‑mediated nausea. Compared with dopamine antagonists or antihistamines, it generally provides superior control of chemotherapy‑induced emesis with a lower incidence of sedation.

Store Ondansetron Kalceks at room temperature, below 25 °C, in the original packaging. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain potency.

Ondansetron Kalceks is administered orally, typically as a tablet swallowed with water. In some clinical settings, a parenteral formulation may be used, but the oral tablet is the standard route for this product.

Serious risks include QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, and serotonin syndrome when combined with other serotonergic agents. Patients should be monitored for these events, especially if they have pre‑existing cardiac conditions.

Ondansetron Kalceks should be avoided in patients with known hypersensitivity to ondansetron or any component of the formulation, those taking apomorphine, and individuals with a history of significant QT prolongation unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT